UnitedHealth Group Incorporated
NYSE:UNHMedical - Healthcare Plans
+$3.69 today
- Market cap
- $313.53B
- Beta
- 0.65
- P/E (TTM)
- 30.5
- EPS (TTM)
- $13.24
- Dividend yield
- 2.22%
Volume 17.34M
Average 8.23M
UNH Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
UnitedHealth Group IncorporatedNYSE: UNH
Depreciation & Amortization · Q3 FY2026 · quarter ended Sep 2026
Depreciation & amortization declines year over year
Q3 FY2026 depreciation & amortization of $1.07B fell 2.4% year over year, behind the -0.6% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 3.2% from the prior quarter. Over 3 fiscal years it compounded at +8.7% a year.
Context
- Depreciation & amortization amounted to 1.0% of revenue in FY2025, unchanged from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -2.4% toward the trailing-twelve-month pace of -0.6%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 4.36B USD
- Year-over-year change
- +6.4%
- 4-year CAGR
- +8.9%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.36B | +6.4% |
| FY2024 | 2024-12-31 | 4.1B | +3.2% |
| FY2023 | 2023-12-31 | 3.97B | +16.8% |
| FY2022 | 2022-12-31 | 3.4B | +9.6% |
| FY2021 | 2021-12-31 | 3.1B | — |
Depreciation & Amortization vs competitors
How UNH compares with its peers on the latest reported figures
- UNH's LTM Sep 2026 depreciation & amortization of $4.26B is the 2nd largest of the 9 companies compared; the peer median is $1B.
- Its year-over-year change of -0.6% is the 3rd highest of 9, against a peer median of -2.8%.
- Depreciation & amortization amounts to 0.9% of revenue for UNH, versus a peer median of 0.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $4.52B | -2.4% | +2.9% | 1.1% | |
| LTM Sep 2026 | $4.26B | -0.6% | +8.7% | 0.9% | |
| LTM Sep 2026 | $2.89B | +7.2% | -1.9% | 1.0% | |
| LTM Sep 2026 | $1.49B | -3.2% | -2.6% | 0.7% | |
| LTM Jun 2026 | $1.25B | -0.8% | -6.4% | 0.6% | |
| LTM Sep 2026 | $763M | -12.3% | -0.8% | 0.5% | |
| LTM Sep 2026 | $161M | -19.1% | +3.5% | 0.4% | |
| LTM Mar 2026 | $30.72M | +7.2% | +21.8% | 0.7% | |
| LTM Jun 2026 | $28.24M | -7.2% | +23.6% | 0.2% | |
| Peer median (excluding UNH) | $1B | -2.8% | +1.0% | 0.7% | |
Competitors are the stored peer set for UNH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 17.29B | 20.12B | 22.38B | 15.24B | 12.81B |
| Depreciation & Amortization | 3.1B | 3.4B | 3.97B | 4.1B | 4.36B |
| Deferred Income Tax | (814M) | (673M) | (245M) | (296M) | (989M) |
| Stock-Based Compensation | 800M | 925M | 1.06B | 1.02B | 971M |
| Change in Working Capital | 1.52B | 2.25B | 1.64B | (808M) | 2.28B |
| Accounts Receivables | (1B) | (2.52B) | (3.11B) | (1.44B) | 0 |
| Inventory | (1.03B) | 0 | 1.04B | 0 | 0 |
| Accounts Payables | 3.86B | 1.96B | 3.52B | 2.46B | 0 |
| Other Working Capital | (310M) | 2.81B | 203M | (1.83B) | 2.28B |
| Other Non-Cash Items | 447M | 188M | 258M | 4.95B | 265M |
| Operating Cash Flow | 22.34B | 26.21B | 29.07B | 24.2B | 19.7B |
| Capital Expenditures | (2.45B) | (2.8B) | (3.39B) | (3.5B) | (3.62B) |
| Acquisitions (Net) | (4.82B) | (21.46B) | (10.14B) | (13.41B) | (4.51B) |
| Purchases of Investments | (1.84B) | (18.83B) | (18.31B) | (27.31B) | 0 |
| Sales of Investments | 15.3B | 11.99B | 16.54B | 27.83B | 361M |
| Other Investing Activities | (16.55B) | 2.62B | (275M) | (4.15B) | (915M) |
| Investing Cash Flow | (10.37B) | (28.48B) | (15.57B) | (20.53B) | (8.69B) |
| Debt Repayment | 2.48B | 12.54B | 4.28B | 14.66B | 726M |
| Common Stock Issued | 1.36B | 1.25B | 1.35B | 1.85B | 0 |
| Common Stock Repurchased | (5B) | (7B) | (8B) | (9B) | (5.55B) |
| Dividends Paid | (5.28B) | (5.99B) | (6.76B) | (7.53B) | (7.92B) |
| Other Financing Activities | 344M | 3.43B | (2.4B) | (3.49B) | 1.09B |
| Financing Cash Flow | (7.46B) | 4.23B | (11.53B) | (3.51B) | (11.64B) |
| Effect of Forex Changes | (62M) | 34M | 97M | (280M) | 3.44B |
| Net Change in Cash | 4.45B | 1.99B | 2.06B | (115M) | 2.81B |
| Free Cash Flow | 19.89B | 23.4B | 25.68B | 20.71B | 16.08B |
UnitedHealth Group Incorporated
NYSE:UNH
Intrinsic Alpha fair value
Locked
Current Price
$349.91
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.